PACS医疗集团
PACS
46.91
-0.84
-1.76%
PACS医疗集团
US · PACS
#1809 按市值排名
上市于 2024
46.91
-0.84
-1.76%
实时 - 追踪5344个代码 - 心跳于507秒前
· 2026-10-16 20:02
最新新闻
-
评级变动
J.P. Morgan Maintains PACS Group(PACS.US) With Buy Rating, Raises Target Price to $58\u5e02\u573a\u8d44\u8baf · 2026/9/4
-
Form 144 | PACS Group(PACS.US) Officer Proposes to Sell 6.43 Million in Common Stocks\u5e02\u573a\u8d44\u8baf · 2026/9/16
-
评级变动
Truist Financial Initiates PACS Group(PACS.US) With Buy Rating, Announces Target Price $52\u5e02\u573a\u8d44\u8baf · 2026/6/15
-
评级变动
UBS Maintains PACS Group(PACS.US) With Buy Rating, Raises Target Price to $60\u5e02\u573a\u8d44\u8baf · 2026/8/7
-
评级变动
Oppenheimer Maintains PACS Group(PACS.US) With Buy Rating, Raises Target Price to $57\u5e02\u573a\u8d44\u8baf · 2026/8/10
-
评级变动
Truist Financial Maintains PACS Group(PACS.US) With Buy Rating\u5e02\u573a\u8d44\u8baf · 2026/9/2
-
评级变动
J.P. Morgan Maintains PACS Group(PACS.US) With Buy Rating, Maintains Target Price $58\u5e02\u573a\u8d44\u8baf · 2026/9/8
-
公司公告
4: PACS Group | 4: Statement of changes in beneficial ownership of securities-Director LEAVITT TAYLOR S.SEC · 2026/7/7
-
公司公告
PACS Group | 8-K: PACS Group, Inc. Reports First Quarter 2026 ResultsSEC · 2026/5/12
-
Form 144 | PACS Group(PACS.US) Officer Proposes to Sell 6.61 Million in Common Stocks\u5e02\u573a\u8d44\u8baf · 2026/9/16
-
PACS Group(PACS.US) 10% Shareholder Sells US$3.5 Million in Common Stock\u5e02\u573a\u8d44\u8baf · 2026/10/6
-
公司公告
4: PACS Group | 4: Statement of changes in beneficial ownership of securities-Director LEAVITT TAYLOR S.SEC · 2026/6/13
-
评级变动
UBS Maintains PACS Group(PACS.US) With Buy Rating, Raises Target Price to $57\u5e02\u573a\u8d44\u8baf · 2026/7/8
-
Form 144 | PACS Group(PACS.US) Officer Proposes to Sell 11.21 Million in Common Stocks\u5e02\u573a\u8d44\u8baf · 2026/9/11
-
评级变动
Truist Financial Maintains PACS Group(PACS.US) With Buy Rating, Announces Target Price $62\u5e02\u573a\u8d44\u8baf · 2026/8/7
-
评级变动
J.P. Morgan Maintains PACS Group(PACS.US) With Buy Rating, Raises Target Price to $47\u5e02\u573a\u8d44\u8baf · 2026/6/23
-
公司公告
8-K: PACS Group | 8-K: PACS Group, Inc. Reports Second Quarter 2026 ResultsSEC · 2026/8/5
-
评级变动
RBC Capital Maintains PACS Group(PACS.US) With Buy Rating, Raises Target Price to $57\u5e02\u573a\u8d44\u8baf · 2026/8/6
-
公司公告
PACS Group | 8-K: PACS Group, Inc. Reports Fiscal Year and Fourth Quarter 2025 ResultsSEC · 2026/2/27
-
PACS Group(PACS.US) 10% Shareholder Sells US$13.04 Million in Common Stock\u5e02\u573a\u8d44\u8baf · 2026/9/16
新闻标题为自动聚合内容,未经我们团队独立核实或编辑。
报价时间 2026-10-16 20:02:15 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
PACS医疗集团 讨论区 0 条评论